The 3rd NASH Summit Europe is the only niche, discussion orientated conference solely dedicated to addressing these hurdles, assessing clinical appetite and advancing NASH pipelines towards success.
Across 3 packed days, join Europe’s NASH stakeholders as they lead directive discussions, share actionable insights and analyse the next 12 months of NASH drug development through a tighter lens.
• Address pharma-physician disconnect in Europe with the EMA
• Understand considerations from European Health Technology Assessment Bodies when assessing the value of medicines for NASH with NICE
• Review regulatory guidance for NASH with compensated cirrhosis with the FDA